BreakingNews $MFTH Medisafe 1 Technologies Advances Negotiations for LifesavingDevice Created by Inventors of Iron Dome Missile Defense System
prnewswire
JERUSALEM,June 6, 2011 /PRNewswire-FirstCall/ -- Medisafe 1 Technologies Corp.(OTCBB:MFTH.ob - News), a developer of patented technologies thatphysically prevent unauthorized administration of prescriptionmedications, announced today that the company has advanced negotiationswith a group of engineers that has developed a potentially breakthroughmedical technology (patent pending) that alerts Emergency MedicalTechnicians and healthcare providers when an individual is in need ofadvanced medical treatment.
The research and development group aswell as the inventors of this technology are the inventors of the nowfamous Iron Dome security system, employed in Israel to automaticallyshoot down incoming missiles fired at major population centers.
Thepotentially lifesaving technology is a band that is worn by individualswho have pre-existing medical conditions that may instantly requireimmediate intensive medical care. The band detects critical vital signsof the individual and sends an automatic alert if levels indicate thatimminent intensive care may be required. The advanced alert enablespatients to get the medical care they need before critical levels becomeuntreatable.
"Medisafe 1 Technologies is advancing efforts toacquire new technologies and expand the ability of our company to markettechnologies that reduce the numbers of patient casualties at hospitalsand medical centers," said Jacob Elhadad, CEO of Medisafe 1Technologies Corp. "The developers of the band technology have alreadyproven their ability to create life-saving devices."
"We look forward to the possibility of adding their new band technology to our commercial product line," Elhadad added.
About Medisafe 1 Technologies
Medisafe1 Technologies seeks to effectively prevent unauthorized administrationof a drug or medicinal substance by hypodermic needle. Medisafe'spatented technology is a medical assembly with a locking mechanism thatis intended to ensure the substance cannot be released from thehypodermic needle without positive pre-matching between the substanceand its intended patient.
Forward-Looking Statements
Thisletter contains forward-looking statements within the meaning of Section27A of the Securities Act of 1933 as amended and Section 21E of theSecurities Exchange Act of 1934 as amended. All forward-lookingstatements are inherently uncertain, based on current expectations andassumptions concerning future events or future performance of Medisafe 1Technologies Corp., and its technologies. In evaluating suchstatements, prospective investors should review carefully various risksand uncertainties identified in this release, as actual results maydiffer materially from those indicated. Medisafe 1 Technologies Corp.public filings may be viewed at
https://www.sec.gov.
Contact:
Jacob Elhadad
CEO
+972-524440000
Jacob.elhadad10@gmail.com